Long-Term Clinical Outcomes After Filter Protection During Percutaneous Coronary Intervention in Patients With Attenuated Plaque 　- 1-Year Follow up of the VAMPIRE 3 (Vacuum Aspiration Thrombus Reemoval 3) Trial.

CONCLUSIONS: In ACS patients with attenuated plaque ≥5 mm, the 1-year rates of MACE were higher in the DP group than in the CT group. This effect might be mitigated by the use of drug-eluting stents.
PMID: 33268603 [PubMed - as supplied by publisher]

Source: Circulation Journal - December 1, 2020 Category: Cardiology Authors: Hibi K, Kozuma K, Maejima N, Sonoda S, Endo T, Tanaka H, Kyono H, Koshida R, Ishihara T, Awata M, Kume T, Tanabe K, Morino Y, Tsukahara K, Ikari Y, Fujii K, Yamasaki M, Yamanaka T, Sumiyoshi T, Yoshino H, Kimura K, Isshiki T, VAMPIRE 3 Investigators Tags: Circ J Source Type: research